Država: Singapur
Jezik: engleski
Izvor: HSA (Health Sciences Authority)
Indacaterol maleate 0.194mg eqv Indacaterol (micronized)
NOVARTIS (SINGAPORE) PTE LTD
R03AC18
0.150mg
CAPSULE
RESPIRATORY (INHALATION)
Prescription Only
Novartis Pharma Stein AG
2011-07-18
1 1. NAME OF THE MEDICINAL PRODUCT Onbrez ® Breezhaler ® 150 microgram inhalation powder, hard capsules Onbrez ® Breezhaler ® 300 microgram inhalation powder, hard capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ONBREZ BREEZHALER 150 MICROGRAM INHALATION POWDER, HARD CAPSULES Each capsule contains indacaterol maleate equivalent to 150 microgram indacaterol. The delivered dose leaving the mouthpiece of the Onbrez Breezhaler inhaler is indacaterol maleate equivalent to 120 microgram indacaterol. Excipients: Each capsule contains 24.8 mg lactose. For a full list of excipients, see section 6.1. ONBREZ BREEZHALER 300 MICROGRAM INHALATION POWDER, HARD CAPSULES Each capsule contains indacaterol maleate equivalent to 300 microgram indacaterol. The delivered dose leaving the mouthpiece of the Onbrez Breezhaler inhaler is indacaterol maleate equivalent to 240 microgram indacaterol. Excipients: Each capsule contains 24.6 mg lactose. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Inhalation powder, hard capsule ONBREZ BREEZHALER 150 MICROGRAM INHALATION POWDER, HARD CAPSULES Natural transparent uncolored capsules containing a white powder, with “IDL 150” printed in black above and company logo ( ) printed in black below a black bar. ONBREZ BREEZHALER 300 MICROGRAM INHALATION POWDER, HARD CAPSULES Narural transparent uncolored capsules containing a white powder, with “IDL 300” printed in blue above and company logo ( ) printed in blue below a blue bar. 2 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Onbrez Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (COPD). Pročitajte cijeli dokument